MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
BBIO — BridgeBio Pharma, Inc. Common Stock
NasdaqBridgeBio Pharma, Inc. Common Stock
$67.25
+0.34(+0.51%)
- O
- 67.10
- H
- 68.68
- L
- 66.23
- V
- 2.65M
⏱️ End-of-day dataAs of Oct 2, 2026
BBIO — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $87.99M | $57.01M | $64.30M | $74.90M | $54.06M | $68.11M |
| Other Short Term Investments | $60.30M | $17.36M | $2.99M | $7.94M | N/A | 0.00 |
| Accounts Receivable | $20.52M | $13.94M | $11.65M | $76.87M | $11.53M | $4.72M |
| Inventory | $32.98M | $26.75M | $24.53M | $18.28M | $3.95M | N/A |
| Other Current Assets | $62.91M | $44.07M | $52.40M | $60.24M | $35.35M | $34.74M |
| Total Current Assets | $124.13M | $79.77M | $83.94M | $91.23M | $69.52M | $72.07M |
| Properties | $22.17M | $13.52M | $12.38M | $12.29M | $13.86M | $12.78M |
| Goodwill | $27.36M | $28.08M | $28.80M | $29.51M | $27.80M | $23.93M |
| Investments And Advances | $61.53M | $79.97M | $92.17M | $10.80M | $12.82M | $14.37M |
| Other Non Current Assets | $18.62M | $16.71M | $25.52M | $18.11M | $16.61M | $18.20M |
| Total Non Current Assets | $12.97M | $13.83M | $15.89M | $16.79M | $18.65M | $19.86M |
| Total Assets | $137.10M | $93.60M | $99.83M | $108.02M | $88.16M | $91.93M |
| Accounts Payable | $29.06M | $36.23M | $18.70M | $26.13M | $27.52M | $9.62M |
| Accrued Expenses | $16.85M | $15.04M | $11.88M | $87.90M | $67.94M | $67.34M |
| Short Term Debt | $55.19M | $6.19M | $5.29M | $4.78M | $5.21M | $4.51M |
| Deferred Revenue | $27.60M | $18.41M | $9.09M | $10.54M | $11.62M | $14.60M |
| Pensions | $39.34M | $76.70M | $56.16M | $37.19M | $33.45M | $58.33M |
| Total Current Liabilities | $81.64M | $28.80M | $21.66M | $17.59M | $15.21M | $15.44M |
| Long Term Debt | $194.03M | $185.63M | $185.44M | $185.36M | $185.30M | $172.61M |
| Other Non Current Liabilities | 229,000.00 | 244,000.00 | 679,000.00 | 545,000.00 | 352,000.00 | 286,000.00 |
| Total Non Current Liabilities | $282.35M | $272.46M | $270.44M | $268.28M | $236.82M | $222.25M |
| Total Liabilities | $363.99M | $301.26M | $292.10M | $285.86M | $252.03M | $237.69M |
| Common Stock | 204,000.00 | 202,000.00 | 200,000.00 | 198,000.00 | 197,000.00 | 196,000.00 |
| Retained Earnings | $-398.52M | $-382.12M | $-362.83M | $-344.56M | $-326.37M | $-309.63M |
| Other Shareholders Equity | -8,000.00 | 12,000.00 | 2,000.00 | 1,000.00 | 0.00 | 8,000.00 |
| Total Shareholders Equity | $-226.89M | $-207.66M | $-192.27M | $-177.84M | $-163.87M | $-145.76M |
| Additional Paid In Capital | $211.25M | $205.76M | $201.83M | $198.08M | $193.84M | $190.32M |
| Treasury Stock | $40.58M | $32.33M | $32.33M | $32.33M | $32.33M | $27.50M |
| Minority Interest | $9.49M | $10.03M | $10.34M | $9.44M | $9.73M | $10.29M |
| Other Current Liabilities | N/A | N/A | $8.60M | $7.21M | $6.36M | N/A |
| Tax Payable | N/A | N/A | N/A | $2.10M | N/A | N/A |
| Restricted Cash | N/A | N/A | N/A | N/A | N/A | 126,000.00 |